PharmaCielo Ltd. (PCLOF) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

PharmaCielo Ltd.

PCLOF

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

6M

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Jun 2025

6M

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Jun 2025

0.04USD

-0.01 ( -20.18%)

After-hours 0.04$

0.01 (13.48%)

Market Open

Relative Strenght

Volume Buzz

-93%

Earning Acce

No

Dist 52w H.

84%

Quote Panel

Updated April 22, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

Relative Strength

PCLOF

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.02
vs -0.02

Q2.23

N/A

-0.02
vs -0.02

Q3.23

N/A

-0.01
vs -0.03

Q4.23

N/A

-0.03
vs -0.01

Q1.24

N/A

-0.01
vs -0.02

Q2.24

N/A

-0.01
vs -0.02

Q3.24

N/A

-0.01
vs -0.01

Q4.24

N/A

-0.01
vs -0.03

Q1.25

N/A

-0.10
vs -0.01

Q2.25

N/A

-0.05
vs -0.01

Sales Growth

YoY

Current

Estimates

Q1.23

-35%

786.5K vs 1.2M

Q2.23

-92%

159.5K vs 2.1M

Q3.23

-26%

351.7K vs 475.3K

Q4.23

-84%

244K vs 1.5M

Q1.24

-69%

240.3K vs 786.5K

Q2.24

+391%

783.7K vs 159.5K

Q3.24

+278%

1.3M vs 351.7K

Q4.24

+362%

1.1M vs 244K

Q1.25

+193%

703.7K vs 240.3K

Q2.25

-81%

147.1K vs 783.7K

Return on Equity

QoQ

Q1.23

-81%

-0.81
vs -0.66

Q2.23

-101%

-1.01
vs -0.81

Q3.23

-99%

-0.99
vs -1.01

Q4.23

+381%

3.81
vs -0.99

Q1.24

+72%

0.72
vs 3.81

Q2.24

+47%

0.47
vs 0.72

Q3.24

+35%

0.35
vs 0.47

Q4.24

+20%

0.2
vs 0.35

Institutionnal Ownership

Earnings Growth

Latest News

PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Reports Q4 2024 Financial Results

PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing

PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Reports Q3 2024 Financial Results

PCLOF

newsfilecorp.com

7 hours ago

PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024

PCLOF

newsfilecorp.com

12 hours ago

PharmaCielo Announces Intention to Extend Expiry Date of Warrants

PCLOF

newsfilecorp.com

16 hours ago

PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024